Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure

Part of paid clinical trials in Gainesville, Florida.

Sponsor
University of Florida
Study ID
NCT06979726
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Lasix ONYU — DRUG
    Providing subcutaneous furosemide to eligible patients

Study Details

The primary objective of the study is to develop, implement, and evaluate a site-specific clinical pathway for at-home treatment of eligible patients presenting to the clinic with worsening heart failure. The secondary objectives are: 1. To evaluate patient factors related to parenteral decongestion at home. 2. To evaluate the safety and device operation of Lasix ONYU treatment under circumstances that mimic real-world use. 3. To identify opportunities for process improvement before the routine implementation of the new clinical pathway.

Key Dates

Start date
Nov 20, 2025
Status verified
Jun 2026
Primary completion
Nov 30, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: Lasix ONYU
    Patients receiving Lasix ONYU

Primary Outcome Measure

Safety of Lasix ONYU Use [ Time Frame: 30 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of FloridaGainesvilleFlorida32608
Mustafa Ahmed, MD

Find similar trials in Gainesville, FL

By condition
Heart failure
By specialty
CardiologyHeart disease
By research site
University of Florida· Gainesville, FL

Related Studies